Insiders / Thompson Peter A. / Activity
Activity — Thompson Peter A.
41 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.53M | -236K -6.77% | 3,247,025 7.18% of shares | medium |
| Apr 16, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.29M | -227K -6.99% | 3,020,119 6.68% of shares | medium |
| May 11, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $8.53M | -185K -6.46% | 2,671,822 5.91% of shares | medium |
| May 8, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.66M | -60K -2.05% | 2,856,461 6.32% of shares | medium |
| Apr 17, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.34M | -52K -1.73% | 2,967,722 6.56% of shares | medium |
| May 7, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.17M | -49K -1.64% | 2,916,228 6.45% of shares | medium |
| Apr 14, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.13M | -48K -1.35% | 3,482,888 7.70% of shares | medium |
| Feb 3, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $1.30M | -29K -0.82% | 3,530,702 7.81% of shares | medium |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $450.0K | +30K | 30,000 0.04% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $187.5K | +15K +33.33% | 60,000 0.07% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $145.5K | +15K +50.00% | 45,000 0.05% of shares | low |
| Apr 18, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $131.2K | -3K -0.10% | 2,964,774 6.56% of shares | medium |
| Feb 2, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $84.2K | -2K -0.05% | 3,559,765 7.87% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $54.1K | +15K +25.00% | 75,000 0.09% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $49.0K | +15K +16.67% | 105,000 0.12% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $41.1K | +15K +14.29% | 120,000 0.14% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $39.0K | +15K +12.50% | 135,000 0.16% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $37.4K | +15K +9.09% | 180,000 0.21% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $31.8K | +15K +7.69% | 210,000 0.25% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $30.0K | +15K +20.00% | 90,000 0.11% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $24.6K | +15K +8.33% | 195,000 0.23% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $14.8K | +15K +11.11% | 150,000 0.18% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Common Stock | $14.5K | +15K +10.00% | 165,000 0.20% of shares | low |
| May 27, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $4.5K | -101 -0.00% | 2,671,721 5.91% of shares | low |
| Jun 24, 2026 | Grant | SPRY ARS Pharmaceuticals, Inc. Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 17, 2026 | Grant | SION Sionna Therapeutics, Inc. Non-Qualified Stock Option (right to buy) | — | +17K | 17,340 0.04% of shares | low |
| Jun 5, 2026 | Grant | EWTX Edgewise Therapeutics, Inc. Stock Option (Right to Buy) | — | +16K | 16,377 0.02% of shares | low |
| Jun 11, 2026 | Grant | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Jan 28, 2026 | Exercise | CRVS Corvus Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -30K -100.00% | 0 0.00% of shares | low |